drugset / Trial / NCT00717561
A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess if a therapy with oral and intravenous moxifloxacin is as effective as a therapy with intravenous ceftriaxone + intravenous azithromycin followed by oral amoxicilline/clavulanate and oral clarithromycin in the treatment of community-acquired pneumonia.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-05
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicilline/clavulanate | Unknown | 1000 mg | Oral |
| Comparator | Azithromycin | Small molecule | 500 mg | Intravenous |
| Comparator | Ceftriaxone | Other / unclassified | 2 g | Intravenous |
| Comparator | Clarithromycin | Small molecule | 500 mg | Oral |
| Subject | Moxifloxacin | Small molecule | 400 mg | Intravenous |